Related Experiment Videos
Inhibition of influenza virus uncoating by rimantadine hydrochloride
Abstract:
In freeze-thaw lysates of MDCK cells infected with 32P-labeled influenza virus A/WSN in the presence of added RNase, acid-precipitable radioactivity diminished to about 50% of initial values within 90 min after a 1-h virus adsorption period. A similar preparation containing rimantadine at a concentration of 50 micrograms/ml exhibited only a 10% reduction in acid-precipitable radioactivity. These findings suggest that rimantadine interferes with uncoating of influenza virus in infected cells.
Insights
Rimantadine inhibits influenza virus uncoating in infected cells. This antiviral drug prevents the virus from releasing its genetic material, significantly reducing viral replication and spread.
Area of Science:
- Virology
- Antiviral drug research
- Cell biology
Background:
- Influenza A virus is a significant human pathogen.
- Antiviral drugs are crucial for managing influenza infections.
- Understanding viral uncoating is key to developing new therapies.
Purpose of the Study:
- To investigate the effect of rimantadine on influenza virus uncoating.
- To determine if rimantadine interferes with the early stages of viral replication.
Main Methods:
- MDCK cells were infected with 32P-labeled influenza virus A/WSN.
- Freeze-thaw lysates were prepared in the presence of RNase.
- Acid-precipitable radioactivity was measured to assess viral RNA integrity.
Main Results:
- In infected cells without rimantadine, acid-precipitable radioactivity decreased by approximately 50% within 90 minutes.
- In cells treated with 50 micrograms/ml rimantadine, radioactivity reduction was only 10%.
Conclusions:
- Rimantadine significantly inhibits the uncoating process of influenza virus.
- This suggests rimantadine's antiviral mechanism involves blocking viral entry into the host cell's replication machinery.